Heliant Ventures Overview
- Investor Type
-
Venture Capital
- Investments
-
3
- Portfolio
-
1
- Exits
-
2

Heliant Ventures General Information
Business Details
Website
www.heliantventures.comYear Founded
Primary Investor Type
Corporate Office
- &th Floor, Kin On Commercial Building
- 49-51 Jervois Street
- Hong Kong
- Hong Kong
Heliant Ventures Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Geneformics | 01-Sep-2014 | Seed Round | Media and Information Services (B2B) | Out of Business | ||
Sanguine | 21-Feb-2013 | Other Healthcare Technology Systems | Generating Revenue | |||
Silentium | 01-Sep-2012 | Electrical Equipment | Generating Revenue |
Heliant Ventures Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Sanguine | 16-Mar-2022 | Secondary Transaction - Private | |
Geneformics | 15-May-2018 |
Heliant Ventures Investments by Industry, Year, and Region
Heliant Ventures FAQs
-
When was Heliant Ventures founded?
Heliant Ventures was founded in 2012.
-
Where is Heliant Ventures headquartered?
Heliant Ventures is headquartered in Hong Kong, Hong Kong.
-
How many investments has Heliant Ventures made?
Heliant Ventures has made 3 investments.
-
What has Heliant Ventures invested in?
Heliant Ventures has made numerous investments in companies like Geneformics, Sanguine, and Silentium within the Media and Information Services (B2B), Healthcare Technology Systems, and Electrical Equipment industries.
-
What has Heliant Ventures invested in recently?
Heliant Ventures's latest investment was on 01-Sep-2014 in Geneformics, a company within the Media and Information Services (B2B) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »